Rheumatologists’ knowledge, attitude and current management of fatigue in patients with rheumatoid arthritis (RA)

被引:0
|
作者
Han Repping-Wuts
Piet van Riel
Theo van Achterberg
机构
[1] Radboud University Nijmegen Medical Centre,Department Rheumatology/495
[2] Radboud University Nijmegen Medical Centre,Department Rheumatology/470
[3] Radboud University Nijmegen Medical Centre,Institute for Quality of Healthcare (IQ
来源
Clinical Rheumatology | 2008年 / 27卷
关键词
Attitude; Fatigue; Knowledge; Management; Rheumatoid arthritis; Rheumatologist;
D O I
暂无
中图分类号
学科分类号
摘要
To describe rheumatologists’ knowledge, attitude and current management of fatigue in patients with rheumatoid arthritis (RA), a postal questionnaire was sent to all rheumatologists (N = 204) and trainees (N = 49), members of the Dutch Society of Rheumatology. The overall response rate was 44% (N = 110). In general, rheumatologists’ knowledge about RA-related fatigue was in accordance with the literature but they perceive a lack of their own knowledge about aetiology and evidence-based interventions to prevent and treat fatigue. The majority of the rheumatologists believe that fatigue is a multi-disciplinary diagnosis and is preferably managed by the nurse specialist (34%). Assuming that the patient will raise the issue, most of the rheumatologists pay attention to fatigue during the first consultation and less often during follow-up consultations. There is a need for knowledge about causes and treatments for RA-related fatigue to ensure that patient outcomes are improved.
引用
收藏
页码:1549 / 1555
页数:6
相关论文
共 50 条
  • [31] Fatigue in rheumatoid arthritis patients
    Papastergiou, K.
    Xanthopoulou, A.
    Lavdaniti, M.
    SCIENTIFIC CHRONICLES, 2014, 19 (03) : 254 - 262
  • [32] Impact of rheumatoid arthritis (RA) core set measures on rheumatologists' judgment of disease activity
    Aletaha, D
    Machold, KP
    Nell, VPK
    Smolen, JS
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S124 - S125
  • [33] Rheumatologists' optimal choice of first-line rheumatoid arthritis (RA) therapy in 2002
    Erkan, D
    Yazici, Y
    Harrison, M
    Paget, SA
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 537 - 537
  • [34] Current management of rheumatoid arthritis
    Genovese, MC
    Davis, JS
    HOSPITAL PRACTICE, 2001, 36 (02): : 21 - +
  • [35] CURRENT PROFILE OF COMORBIDITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN COMPARISON TO COMMUNITY CONTROLS
    Sokka, T.
    Kautiainen, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 356 - 356
  • [36] Adalimumab (HUMIRA®) monotherapy significantly improves fatigue in patients with severe rheumatoid arthritis (RA)
    Dietz, BM
    Sterz, R
    Holtbrügge, W
    Kupper, H
    Van de Putte, LBA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 392 - +
  • [37] POOR COMPLIANCE BY RHEUMATOLOGISTS AND ORTHOPAEDISTS WITH GUIDELINES FOR THE PERIOPERATIVE MANAGEMENT OF RHEUMATOID ARTHRITIS PATIENTS UNDERGOING ARTHROPLASTY
    Murray, Kieran
    Cassidy, Tristan
    Abdalla, Abuelmagd
    Murray, Timothy
    O'rourke, Anna
    Veale, Douglas
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 346 - 346
  • [38] RHEUMATOLOGISTS' LACK OF UNDERSTANDING AND DISCOUNTING FOR PATIENTS WITH FIBROMYALGIA AND RHEUMATOID ARTHRITIS
    Kool, M. B.
    Venhuizen, A. C.
    van Middendorp, H.
    Jacobs, J. W. G.
    Bijlsma, J. W.
    Geenen, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 368 - 368
  • [39] RHEUMATOLOGISTS' LACK OF UNDERSTANDING AND DISCOUNTING FOR PATIENTS WITH FIBROMYALGIA AND RHEUMATOID ARTHRITIS
    Kool, M. B.
    Venhuizen, A. C.
    van Middendorp, H.
    Jacobs, J. W. G.
    Bijlsma, J. W.
    Geenen, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1071 - 1071
  • [40] Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis
    Bertrand, Delphine
    Deprez, Anke
    Doumen, Michael
    De Cock, Diederik
    Pazmino, Sofia
    Marchal, Anja
    Thelissen, Marc
    Joly, Johan
    De Meyst, Elias
    Neerinckx, Barbara
    Westhovens, Rene
    Verschueren, Patrick
    MUSCULOSKELETAL CARE, 2024, 22 (02)